Search results
Is This New Medication Another Solution For High Cholesterol?
HuffPost Life via Yahoo News· 11 months agoBempedoic acid lowered cholesterol in people who are at high risk of heart disease by 21%. Last...
What to Know About High Cholesterol in Kids
Time via Yahoo News· 2 years agoHeart disease is the leading cause of death in the U.S., but it’s not something we usually associate with kids. In many cases, however, the seeds of...
Verve Loses A Third Of Its Value As Safety Concerns Plague Its Gene-Editing Drug
Investor's Business Daily· 7 months agoVerve Therapeutics stock crashed Monday as safety concerns plagued its gene-editing approach to...
US FDA expands use of Regeneron's cholesterol drug in young children
Reuters via Yahoo News· 1 year agoThe drug, Evkeeza, was approved in February 2021 as an additional treatment with other...
How Gene Editing Could Help Solve the Problem of Poor Cholesterol
Time via Yahoo News· 2 years agoCredit - vchal—Getty Images Cardiovascular disease is the leading cause of death in the U.S. and...
If You Invested $1000 in Regeneron 10 Years Ago, This Is How Much You'd Have Now
Zacks via Yahoo Finance· 2 years agoFor most investors, how much a stock's price changes over time is important. This factor can impact...
Gene Editing Experiment Halted as Patient Gets Weird Side Effects
Futurism via Yahoo News· 2 months agoThe experimental biotech startup Verve Therapeutics has paused the first phase of a buzzy human...
Regeneron (REGN) Gets FDA Nod for Praluent Label Extension
Zacks via Yahoo Finance· 3 months agoRegeneron (REGN) obtains FDA approval for Praluent as an adjunct to diet and other LDL-C, lowering...
This New Drug Lowers Cholesterol Without the Side Effects of Statins
Verywell Health via Yahoo News· 1 year agoDrugs called statins have been the go-to for helping people lower their cholesterol and reduce their...
After a Serious Setback, Is Verve Therapeutics a Buy?
Motley Fool via Yahoo Finance· 2 months agoVerve Therapeutics (NASDAQ: VERV) saw its shares crater by 36% on April 2 when it reported that a...